Market Insight | FANGZHOU JIANKE Surges Over 12% and Reaches Strategic Cooperation with Tencent in Multiple Areas such as Digital Healthcare

FANGZHOU JIANKE rose more than 12%, as of the time of publication, it increased by 12.27% to HKD 6.13, with a turnover of HKD 2.2406 million. On the news front, the 9th H2H Medical Service Ecological Conference of FANGZHOU JIANKE was recently held in Shanghai. At the conference, Dr. Xie Fangmin, the founder, chairman, and CEO of FANGZHOU JIANKE, and Yan Peng, Vice President of Tencent Cloud and Vice President of Tencent Health, jointly signed a strategic cooperation agreement. The two parties will deepen cooperation in various areas such as digital healthcare, chronic disease management services, and digital innovation. It is reported that FANGZHOU JIANKE and Tencent will leverage their respective strengths to build a business link through "Tencent Medics," expanding the influence of professional medical popularization and user reach. In addition, in the future, the two parties will continue to integrate the "Tencent Health Medicine Box" cooperation, relying on the WeChat platform to provide more accurate and personalized medication reminders, disease tracking, and other services for each user and patient